{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:27Z","timestamp":1753891047521,"version":"3.41.2"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2023.1323793","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:33:10Z","timestamp":1698751990000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: NK cell defects: diagnosis and treatment"],"prefix":"10.3389","volume":"14","author":[{"given":"Snehal","family":"Shabrish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanmuganathan","family":"Chandrakasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.616853","article-title":"Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases","volume":"12","author":"Gianchecchi","year":"2021","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00301","article-title":"Immunoregulatory role of NK cells in tissue inflammation and regeneration","volume":"8","author":"Tosello-Trampont","year":"2017","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03038","article-title":"Influence of the tumor microenvironment on NK cell function in solid tumors","volume":"10","author":"Melaiu","year":"2020","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00556","article-title":"Small-molecule immunosuppressive drugs and therapeutic immunoglobulins differentially inhibit NK cell effector functions in vitro","volume":"10","author":"Pradier","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.847793","article-title":"Oncogenic KPNA2 serves as a biomarker and immune infiltration in patients with HPV positive tongue squamous cell carcinoma","volume":"12","author":"Gao","year":"2022","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13058-017-0867-9","article-title":"Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours","volume":"19","author":"Shenouda","year":"2017","journal-title":"Breast Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2020.101407","article-title":"NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends","volume":"48","author":"Russick","year":"2020","journal-title":"Semin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24046","article-title":"Immune status of patients with inherited bone marrow failure syndromes","volume":"90","author":"Giri","year":"2015","journal-title":"Am J Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12878-016-0064-6","article-title":"KIR repertory in patients with hematopoietic diseases and healthy family members","volume":"16","author":"Sugioka","year":"2016","journal-title":"BMC Hematol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1323793\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:33:11Z","timestamp":1698751991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1323793\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":11,"alternative-id":["10.3389\/fimmu.2023.1323793"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1323793","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"article-number":"1323793"}}